Found: 10
Select item for more details and to access through your institution.
The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture.
- Published in:
- Liver International, 2013, v. 33, n. 1, p. 127, doi. 10.1111/liv.12011
- By:
- Publication type:
- Article
Treatment effects of the multikinase inhibitor sorafenib on hepatoblastoma cell lines and xenografts in NMRI- Foxn1<sup>nu</sup> mice.
- Published in:
- Liver International, 2012, v. 32, n. 4, p. 574, doi. 10.1111/j.1478-3231.2011.02729.x
- By:
- Publication type:
- Article
In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 6, p. 584, doi. 10.1038/nbt.3241
- By:
- Publication type:
- Article
Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies.
- Published in:
- Molecular & Cellular Pediatrics, 2015, v. 2, n. 1, p. 1, doi. 10.1186/s40348-015-0022-6
- By:
- Publication type:
- Article
A Comparative Study of the Bone Regenerative Effect of Chemically Modified RNA Encoding BMP-2 or BMP-9.
- Published in:
- AAPS Journal, 2017, v. 19, n. 2, p. 438, doi. 10.1208/s12248-016-0034-8
- By:
- Publication type:
- Article
Effect of duplex drugs linking 2′-deoxy-5-fluorouridine (5-FdU) with 3′-C-ethynylcytidine (ECyd) on hepatoblastoma cell lines.
- Published in:
- Pediatric Surgery International, 2013, v. 29, n. 2, p. 121, doi. 10.1007/s00383-012-3192-5
- By:
- Publication type:
- Article
Effect of duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) on hepatoblastoma cell lines.
- Published in:
- 2013
- By:
- Publication type:
- journal article
In vitro evaluation of the Aurora kinase inhibitor VX-680 for Hepatoblastoma.
- Published in:
- Pediatric Surgery International, 2012, v. 28, n. 6, p. 579, doi. 10.1007/s00383-012-3086-6
- By:
- Publication type:
- Article
Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-34960-0
- By:
- Publication type:
- Article
Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0183526
- By:
- Publication type:
- Article